Literature DB >> 10967719

[Drug interactions: a prospective pilot study in primary health care].

N Rémy1, M Lapeyre-Mestre, M P Bareille, H Bagheri, J L Montastruc.   

Abstract

The present prospective pilot study investigated putative drug interactions in primary health care. Among 110 outpatients, 50 were treated with more than one drug (maximum = 10). Among these 50 prescription forms, 21 concerned at least one drug interaction, with a total of 47 different drug interactions. Most of them (94 per cent) were explained by a pharmacodynamic mechanism. They were classified as 'requiring use precautions' (64 per cent), 'to be taken into account' (25 per cent) or 'inadvisable' (11 per cent). None of them was 'contraindicated'. Most often the drugs involved were diuretics, converting enzyme inhibitors or non-steroidal antiinflammatory drugs. Drug interactions, which concern around one in five prescription forms, remain an important topic in Clinical Pharmacology.

Mesh:

Year:  2000        PMID: 10967719

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  5 in total

1.  The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.

Authors:  Francois Montastruc; Agnès Sommet; Emmanuelle Bondon-Guitton; Geneviève Durrieu; Eric Bui; Haleh Bagheri; Maryse Lapeyre-Mestre; Laurent Schmitt; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2011-11-25       Impact factor: 2.953

2.  Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France.

Authors:  Anne Charlotte Danton; François Montastruc; Agnès Sommet; Geneviève Durrieu; Haleh Bagheri; Emmanuelle Bondon-Guitton; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2012-09-21       Impact factor: 2.953

3.  Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999.

Authors:  Laurence Guédon-Moreau; Dominique Ducrocq; Marie-Francoise Duc; Yves Quieureux; Catherine L'Hôte; Jean Deligne; Jacques Caron
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

4.  Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999.

Authors:  Laurence Guédon-Moreau; Dominique Ducrocq; Marie-Francoise Duc; Yves Quieureux; Catherine L'Hôte; Jean Deligne; Jacques Caron
Journal:  Eur J Clin Pharmacol       Date:  2003-10-14       Impact factor: 2.953

5.  Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

Authors:  Neda Tavassoli; Agnes Sommet; Maryse Lapeyre-Mestre; Haleh Bagheri; Jean-Louis Montrastruc
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.